Cargando…
NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis
Cell fate and proliferation ability can be transformed through reprogramming technology. Reprogramming glioblastoma cells into neuron-like cells holds great promise for glioblastoma treatment, as it induces their terminal differentiation. NeuroD4 (Neuronal Differentiation 4) is a crucial transcripti...
Autores principales: | Wang, Hao, Zhao, Peiqi, Zhang, Ying, Chen, Zhen, Bao, Han, Qian, Wenqi, Wu, Jian, Xing, Zhenqiu, Hu, Xiaowei, Jin, Kunlin, Zhuge, Qichuan, Yang, Jianjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427652/ https://www.ncbi.nlm.nih.gov/pubmed/37582760 http://dx.doi.org/10.1038/s41420-023-01595-8 |
Ejemplares similares
-
Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
por: Yan, Xiangying, et al.
Publicado: (2023) -
NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma
por: Cheng, Yan, et al.
Publicado: (2020) -
Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathway
por: Wang, Xingjie, et al.
Publicado: (2023) -
Failure of observing NeuroD1-induced microglia-to-neuron conversion in vitro is not attributed to the low NeuroD1 expression level
por: Rao, Yanxia, et al.
Publicado: (2022) -
PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor
por: Wang, Kankai, et al.
Publicado: (2022)